Novotech News

  1. Novotech Publishes Precision Oncology Landscape Whitepaper Identifying Current Trends And Opportunities In Targeted Therapies 3/14/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an insightful whitepaper, Precision Oncology - Global Clinical Trial Landscape, providing the latest research insights for cancer treatments.

  2. Novotech Publishes Candidiasis And Rheumatoid Arthritis Clinical Trial Landscape Reports To Support Biotech Research Planning 2/19/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released today two industry leading reports on the Candidiasis and Rheumatoid Arthritis clinical trial landscapes.

  3. New Novotech Report Finds 1,000 HIV Clinical Trials Globally 1/10/2024

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape report on HIV, a condition now affecting more than 39 million people.

  4. Early-Stage Biotech Investments Were Down 40% In 2023: Novotech Whitepaper 1/9/2024

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the Navigating the Biotech Landscape whitepaper examining the significant financial shifts that affected the biotech industry in 2023.

  5. Novotech Executive Team At J.P. Morgan Healthcare Conference: Global CRO Designed For Biotechs Across 25 Regions 1/9/2024

    Novotech, a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase announced today that it will have the largest ever presence at the J.P.Morgan Healthcare Conference in San Francisco, CA, USA, January 8-11, 2024.

  6. New Novotech Report On Metastatic Breast Cancer Identifies 1,000 Clinical Trials Globally Since 2018 12/15/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape reports on Metastatic Breast Cancer.

  7. Novotech Identifies Decentralized Clinical Trials Potential And Challenges For Accelerating Global Biotech Clinical Trials In 2024 11/27/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, will be presenting at the Clinical Research Governance (CRGo) World Conference & International Clinical Trial Center Network (ICN) Symposium 2023 in Hong Kong this month.

  8. Novotech Publishes New Reports On Dyslipidaemia And Non-Small Cell Lung Cancer Global Clinical Trial Landscape 11/22/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape reports on dyslipidaemia and non-small cell lung cancer (NSCLC).

  9. Novotech Publishes Whitepaper On Infectious Diseases Clinical Trials, Revealing Over 7,000 Trials Launched Worldwide 11/8/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest 2023 global clinical trial environment whitepaper focused on infectious diseases.

  10. Novotech Opens ChinaTrials 15 Conference With Workshop On How Biotechs Can Accelerate Global Trials 11/7/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, opens the ChinaTrials 15 conference in Shanghai, China with a message to China biotechs about the benefits of conducting simultaneous China, US and Australia trials to accelerate drug development.